Xie and colleagues have demonstrated that ablation of Atg7 in a BRAFV600E/PTENnull melanoma model decreased tumour growth, promoted senescence, and increased survival in comparison to mice that were wildptype for Atg7 [91]. This evidence concerns the gene ATG7 and melanoma.